Skip to main content
. Author manuscript; available in PMC: 2019 Jun 8.
Published in final edited form as: Circ Res. 2018 Apr 27;122(12):1703–1715. doi: 10.1161/CIRCRESAHA.118.312978

Table 3.

Baseline Evaluation

  • Comprehensive review of medical and surgical history, vital signs, and physical examination

  • Current prescription and over-the-counter medications

  • New York Heart Association Classification and Canadian Cardiovascular Society Functional Classification

  • Laboratory tests, including: chemistry tests, complete blood count, liver function tests, NT-proBNP, troponin I/T, HbA1c, PT/INR/PTT, and pregnancy test (childbearing women)

  • Infectious disease tests (institution bone marrow donor panel) including: HIV, Hep B (HBsAg, Anti-HBs, Anti-HBc), and Hep C (Anti-HCV)

  • Cardiac magnetic resonance imaging and implantable cardioverter defibrillator (ICD) interrogation (if applicable)

  • Six-minute walk test

  • 12-lead electrocardiogram

  • Treadmill-based VO2 max

  • Minnesota Living with Heart Failure Questionnaire

  • Sexual function assessment: International Index of Erectile Function for males; Female Sexual Function Index for female

s

NT-Pro BNP= N-Terminal pro-Brain Natriuretic Peptide; HbA1c= Glycated Hemoglobin (A1c); PT/INR/PTT= Prothrombin Time/International Normalized Ratio/ Partial Thromboplastin Time; HIV=Human Immunodeficiency Virus; HBsAg=Hepatitis B surface antigen; Anti-HBs=Hepatitis B surface antibody; Anti-HBc=Hepatitis B core antibody; Anti-HCV= Hepatitis C Virus